SUBSCRIBE
SUBSCRIBE
News   Policy

U.S. Judge Denies Sanofi-Aventis (France)'s Request to Get Lovenox Generic Rival Made by Novartis AG Blocked; Sanofi to Continue Fight

August 26, 2010 | 
1 min read
LONDON, Aug 26 (Reuters) - French drugmaker Sanofi-Aventis (SASY.PA) said it would continue a legal battle in the United States against a generic version of its blood clot preventer Lovenox, despite a court rebuff.
Legal
Novartis Sanofi
MORE ON THIS TOPIC
Recovering losses, effective economic measures to help alleviate inflation or economic crisis resulting in the collapse of the business economy or stock market, helping hands to catch gold coins rolling down a tilted cliff
Patents
Pfizer settles with generic drugmakers to protect blockbuster drug until 2031
April 29, 2026
 · 
2 min read
 · 
Nick Paul Taylor
man pulling each of the opposite ends of a rope in black and white, on a blue background with some blank space on top
Pancreatic cancer
Revolution levels legal threat on Erasca as pancreatic cancer rivalry heats up
April 28, 2026
 · 
3 min read
 · 
Tristan Manalac
Stack of coins balancing on seesaw over a bottle of pills.
Drug pricing
Regeneron finally joins Trump’s drug pricing push while notching landmark approval
April 24, 2026
 · 
2 min read
 · 
Tristan Manalac
Composite photo collage of hands hold picket poster riot agitation strike crowd people democracy solidarity isolated on painted background.
Complete response letters
Unnamed pharma files citizen petition targeting FDA’s trove of rejection letters
April 23, 2026
 · 
2 min read
 · 
Tristan Manalac